Evidence map›Paper›PMID 35984846›Full record

ArticlePloS one2022

Dysregulation of the hippocampal neuronal network by LGI1 auto-antibodies.

Elodie Fels, Marie-Eve Mayeur, Estelle Wayere, Clémentine Vincent, Céline Malleval, Jérôme Honnorat, Olivier Pascual

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Elodie FelsSynaptopathies and Auto-antibodies (SynatAc) Team, Institut NeuroMyoGène, MeLis-CNRS UMR 5284-INSERM U1314, Universités de Lyon, Université Claude Bernard Lyon 1, Lyon, France.
Marie-Eve MayeurSynaptopathies and Auto-antibodies (SynatAc) Team, Institut NeuroMyoGène, MeLis-CNRS UMR 5284-INSERM U1314, Universités de Lyon, Université Claude Bernard Lyon 1, Lyon, France.
Estelle WayereSynaptopathies and Auto-antibodies (SynatAc) Team, Institut NeuroMyoGène, MeLis-CNRS UMR 5284-INSERM U1314, Universités de Lyon, Université Claude Bernard Lyon 1, Lyon, France.
Clémentine VincentSynaptopathies and Auto-antibodies (SynatAc) Team, Institut NeuroMyoGène, MeLis-CNRS UMR 5284-INSERM U1314, Universités de Lyon, Université Claude Bernard Lyon 1, Lyon, France.ORCID 0000-0003-1017-1308
Céline MallevalSynaptopathies and Auto-antibodies (SynatAc) Team, Institut NeuroMyoGène, MeLis-CNRS UMR 5284-INSERM U1314, Universités de Lyon, Université Claude Bernard Lyon 1, Lyon, France.
Jérôme HonnoratSynaptopathies and Auto-antibodies (SynatAc) Team, Institut NeuroMyoGène, MeLis-CNRS UMR 5284-INSERM U1314, Universités de Lyon, Université Claude Bernard Lyon 1, Lyon, France.
Olivier PascualSynaptopathies and Auto-antibodies (SynatAc) Team, Institut NeuroMyoGène, MeLis-CNRS UMR 5284-INSERM U1314, Universités de Lyon, Université Claude Bernard Lyon 1, Lyon, France.ORCID 0000-0002-5730-9880
Université Claude Bernard Lyon 1 · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

LGI1 is a neuronal secreted protein highly expressed in the hippocampus. Epileptic seizures and LGI1 hypo-functions have been found in both ADLTE, a genetic epileptogenic syndrome and LGI1 limbic encephalitis (LE), an autoimmune disease. Studies, based mainly on transgenic mouse models, investigated the function of LGI1 in the CNS and strangely showed that LGI1 loss of function, led to a decreased AMPA-receptors (AMPA-R) expression. Our project intends at better understanding how an altered function of LGI1 leads to epileptic seizures. To reach our goal, we infused mice with LGI1 IgG purified from the serum of patients diagnozed with LGI1 LE. Super resolution imaging revealed that LGI1 IgG reduced AMPA-R expression at the surface of inhibitory and excitatory neurons only in the dentate gyrus of the hippocampus. Complementary electrophysiological approaches indicated that despite reduced AMPA-R expression, LGI1 IgG increased the global hyperexcitability in the hippocampal neuronal network. Decreased AMPA-R expression at inhibitory neurons and the lack of LGI1 IgG effect in presence of GABA antagonist on excitability, led us to conclude that LGI1 function might be essential for the proper functioning of the overall network and orchestrate the imbalance between inhibition and excitation. Our work suggests that LGI1 IgG reduced the inhibitory network activity more significantly than the excitatory network shedding lights on the essential role of the inhibitory network to trigger epileptic seizures in patients with LGI1 LE.

Indexed as

AutoantibodiesEpilepsyHippocampusLimbic Encephalitisalpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic AcidAnimalsHumansImmunoglobulin GIntracellular Signaling Peptides and ProteinsMiceNeuronsReceptors, AMPASeizuresalpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic AcidAutoantibodiesImmunoglobulin GIntracellular Signaling Peptides and ProteinsLgi1 protein, mouseReceptors, AMPA

Identifiers

PMID35984846
PMCPMC9390894
OpenAlexW4292366109

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.